U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C30H29N3O
Molecular Weight 447.5708
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MN-18

SMILES

CCCCCC1=CC=C(CN2N=C(C(=O)NC3=C4C=CC=CC4=CC=C3)C5=C2C=CC=C5)C=C1

InChI

InChIKey=BLOQUZQMKJZVQE-UHFFFAOYSA-N
InChI=1S/C30H29N3O/c1-2-3-4-10-22-17-19-23(20-18-22)21-33-28-16-8-7-14-26(28)29(32-33)30(34)31-27-15-9-12-24-11-5-6-13-25(24)27/h5-9,11-20H,2-4,10,21H2,1H3,(H,31,34)

HIDE SMILES / InChI

Molecular Formula C30H29N3O
Molecular Weight 447.5708
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.233 nM [EC50]
2.028 nM [EC50]
Substance Class Chemical
Created
by admin
on Tue Apr 01 17:08:09 GMT 2025
Edited
by admin
on Tue Apr 01 17:08:09 GMT 2025
Record UNII
GP2N1PG5X2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1H-INDAZOLE-3-CARBOXAMIDE, N-1-NAPHTHALENYL-1-PENTYL-
Preferred Name English
MN-18
Common Name English
N-(NAPHTHALEN-1-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-MN-18
Created by admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
Code System Code Type Description
CAS
1391484-80-2
Created by admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
PRIMARY
FDA UNII
GP2N1PG5X2
Created by admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
PRIMARY
WIKIPEDIA
MN-18
Created by admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
PRIMARY MN 18 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen. MN-18 is banned in Sweden.
MANUFACTURER PRODUCT INFORMATION
MN-18
Created by admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
PRIMARY MN-18 is a synthetic cannabinoid modeled after AKB48 (APINACA, Item No. 11566), with the adamantyl group replaced by a naphthalenyl group. The physiological and toxicological properties of this compound are unknown. This product is intended for forensic and research applications.
EPA CompTox
DTXSID301010033
Created by admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
PRIMARY
PUBCHEM
154925762
Created by admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Ki
TARGET -> AGONIST
Ki
Related Record Type Details
ACTIVE MOIETY